Innovator IBD 50 ETF (FFTY) Holdings $34.09 +0.12 (+0.35%) Closing price 04:00 PM EasternExtended Trading$34.10 +0.00 (+0.01%) As of 04:10 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Holdings Stock AnalysisChartHoldingsOwnershipRatingsShort InterestBuy This Stock Top 25 FFTY HoldingsRankCompanyCurrent PriceWeightShares Held1AGXArgan$236.58+0.7%3.80%13,2362TSSITSS$19.66-11.1%3.66%110,7393HOODRobinhood Markets$114.92+3.3%3.63%28,0324Celestica Inc.N/A3.56%16,9535PLTRPalantir Technologies$187.15+2.7%3.54%18,5076AMSCAmerican Superconductor$51.12-5.9%3.53%66,6097OUSTOuster$26.54+14.9%3.37%107,3748FUTUFutu$159.29+1.7%3.34%16,9439Rocket Lab USA IncN/A3.18%58,22110APHAmphenol$109.74+1.1%3.15%24,354 Get the Latest News and Ratings for FFTY and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Innovator IBD 50 ETF and its competitors with MarketBeat's FREE daily newsletter. 11ALABAstera Labs$177.95+4.1%3.09%20,52912AFRMAffirm$73.59-6.8%3.06%37,36713IRENIREN$18.38-1.0%3.03%150,68614ATIATI$72.88-1.2%3.02%26,06815URBNUrban Outfitters$76.20-2.1%2.96%31,44916JBLJabil$225.92+2.5%2.92%10,70417SYMSymbotic$56.22+3.7%2.92%45,35418ATATAtour Lifestyle$35.56+1.8%2.91%67,64219RYTMRhythm Pharmaceuticals$92.79+0.3%2.90%27,93320CRCLCircle Internet Group$158.11+3.4%2.72%12,11721FIXComfort Systems USA$691.14-0.5%2.51%2,98422VRTVertiv$139.83+0.3%2.17%12,56023NETCloudflare$206.48-1.9%2.09%8,64524IBKRInteractive Brokers Group$65.93+2.6%2.05%25,82325NVDANVIDIA$182.49+0.9%2.05%9,574 Geographic ExposureUnited States97.7%Canada1.8%Currency ExposureUSD100.0%Sector ExposureInformation Technology22.9%Industrials21.3%Financials16.5%Technology10.9%Health Care7.9%Energy5.2%Consumer Discretionary5.0%Capital Markets3.1%Materials2.9%Communication Services1.0%Industry ExposureCapital Markets13.5%Semiconductors & Semiconductor Equipment11.6%Software9.4%Electronic Equipment, Instruments & Components8.4%Electrical Equipment8.4%Construction & Engineering5.3%Health Care Providers & Services4.7%Renewable Energy4.3%Machinery4.1%Aerospace & Defense3.5%Consumer Finance3.4%Biotechnology3.1%Specialty Retail3.0%Metals & Mining2.9%IT Services2.8%Financial Services2.8%Hotels, Restaurants & Leisure2.0%Technology Hardware, Storage & Peripherals1.5%Entertainment1.0%Oil, Gas & Consumable Fuels0.9%SubIndustry ExposureSemiconductors11.3%Investment Banking & Brokerage9.1%Application Software8.5%Electrical Components & Equipment8.4%Health Care Services4.7%Renewable Energy Equipment4.3%Industrial Machinery & Supplies4.1%Asset Management & Custody Banks4.0%Aerospace & Defense3.5%Electronic Components3.4%Specialized Consumer Services3.4%Consumer Finance3.4%Biotechnology3.1%Electronic Equipment & Instruments3.1%Apparel Retail3.0%Internet Services & Infrastructure2.8%Transaction & Payment Processing2.8%Steel2.3%Hotels, Resorts & Cruise Lines2.0%Electronic Manufacturing Services1.9%Construction & Engineering1.9%Technology Hardware, Storage & Peripherals1.5%Interactive Home Entertainment1.0%Systems Software0.9%Oil & Gas Equipment & Services0.9%Diversified Metals & Mining0.5%Financial Exchanges & Data0.4%Semiconductor Materials & Equipment0.4% Related Companies and Tools Related Companies RAYE Portfolio ENZL Portfolio FLAU Portfolio QAT Portfolio BUL Portfolio RFDA Portfolio DVOL Portfolio GIAX Portfolio MKOR Portfolio CRDT Portfolio This page (NYSEARCA:FFTY) was last updated on 8/8/2025 by MarketBeat.com Staff From Our PartnersIs Elon's empire crumbling?The Tesla Shock Nobody Sees Coming While headlines scream "Tesla is doomed"... Jeff Brown has uncovered ...Brownstone Research | SponsoredHIDDEN IN THE BOOK OF GENESIS…“This land I will give to you…” — a 4,000-year-old line from Genesis may hold the key to unlocking a $150 tril...Paradigm Press | SponsoredSell this, buy thatWhat you don’t own matters just as much as what you do. That’s the thinking behind Eric Fry’s long-time strate...InvestorPlace | SponsoredGENIUS Act: Cancel Your Money?A new law called the GENIUS Act could quietly trigger the most radical shift in American finance in decades. B...Priority Gold | SponsoredTrump’s national nightmare is herePorter Stansberry and Jeff Brown say a new U.S. national emergency is already underway — and it could trigger ...Porter & Company | SponsoredHe Called Nvidia at $1.10. Now, He Says THIS Stock Will…The original Magnificent Seven returned 16,894%—turning $7K into $1.18 million. Now, the man who called Nvi...The Oxford Club | SponsoredBREAKING: The House just passed 3 pro-crypto bills!THREE pro-crypto bills just passed the House! Now, experts believe altcoin season is officially here. Crypto 101 Media | SponsoredFormer CIA Officer Reveals How Gold Saved His Life This isn’t just another gold investing book—it’s a survival playbook written by a former CIA officer trained...Advantage Gold | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Innovator IBD 50 ETF Please log in to your account or sign up in order to add this asset to your watchlist. Share Innovator IBD 50 ETF With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
